As the global health crisis caused by COVID-19 continues, InBios is hard at work developing COVID-19 diagnostics. We have several products that are FDA Emergency Use Authorized and continue development of other coronavirus diagnostics. Check this page frequently for updates.
We are also ready to support developers with CoV-2 recombinants and assay development. Inquire here for more information on how we can help.